| Literature DB >> 27610078 |
Rebecca A Lundwall1, Claudia G Rasmussen1.
Abstract
Attention is vital to success in all aspects of life (Meck and Benson, 2002; Erickson et al., 2015), hence it is important to identify biomarkers of later attentional problems early enough to intervene. Our objective was to determine if any of 11 genes (APOE, BDNF, HTR4, CHRNA4, COMT, DRD4, IGF2, MAOA, SLC5A7, SLC6A3, and SNAP25) predicted the trajectory of attentional development within the same group of children between infancy and childhood. We recruited follow up participants from children who participated as infants in visual attention studies and used a similar task at both time points. Using multilevel modeling, we associated changes in the participant's position in the distribution of scores in infancy to his/her position in childhood with genetic markers on each of 11 genes. While all 11 genes predicted reaction time (RT) residual scores, only Monoamine oxidase A (MAOA) had a significant interaction including time point. We conclude that the MAOA single nucleotide polymorphism (SNP) rs1137070 is useful in predicting which girls are likely to develop slower RTs on an attention task between infancy and childhood. This early identification is likely to be helpful in early intervention.Entities:
Keywords: children; early identification; infants; intervention; longitudinal; reflexive attention
Year: 2016 PMID: 27610078 PMCID: PMC4996824 DOI: 10.3389/fnhum.2016.00424
Source DB: PubMed Journal: Front Hum Neurosci ISSN: 1662-5161 Impact factor: 3.169
.
| Gene | Biological effect | Functional effect |
|---|---|---|
| The ε4 haplotype reduces acetylcholine receptor number (Parasuraman et al., | APOE has been associated with visuospatial skills in children (Bloss et al., | |
| This gene is involved in the serotonergic system (Juckel et al., | Related to impulsive-aggressive behaviors in children (Oades et al., | |
| This gene encodes a nicotinic acetylcholine receptor that can bind acetylcholine and open an ion-conducting channel across the plasma membrane. The protein can interact with either nAChR beta-2 or nAChR beta-4 to form a functional receptor (Winterer et al., | Associated to with ADHD in children (Faraone and Mick, | |
| G at rs4680 produces valine which is more active in catabolizing dopamine making dopamine less available (Axelrod and Tomchick, | COMT has been associated with working memory and brain activity during development (Dumontheil et al., | |
| Risk alleles lead to fewer dopamine receptors via reduced transcription (Lowe et al., | There is an association between DRD4, cortical development, and ADHD (Shaw et al., | |
| A member of the family of serotonin receptors; the gene product modulates various neurotransmitters (Lambe et al., | Associated with depression, autism, and ADHD (Faraone and Mick, | |
| This gene encodes a member of the insulin family of polypeptide growth factors, which are involved in development (including DA neuron development) and growth (Riikonen et al., | Epigenetic changes at this locus are associated with developmental growth disorders such as Beckwith-Wiedemann syndrome (Nativio et al., | |
| This gene is on chromosome X. It encodes an enzyme that degrades amine neurotransmitters, such as dopamine and serotonin (Xu et al., | Abnormal regulation of | |
| The presynaptic choline transporter (CHT, SLC5A7) is the major rate-limiting determinant of ACh production in the brain and periphery (Neumann et al., | Upregulated during tasks that require sustained attention (English et al., | |
| Controls the number of dopamine transporter and therefore less dopamine in the synapse (Giros et al., | Less dopamine has been associated with greater attentional costs for targets in the left hemifield of children (Bellgrove et al., | |
| This gene product is a presynaptic plasma membrane protein involved in the regulation of neurotransmitter release, including dopamine (Feng et al., | SNAP25 has been associated with ADHD (Feng et al., |
Note: Biological effects include changes to the gene that alter the way the protein it codes for is produced (e.g., changes in a synaptic receptor, enzyme, or neurotransmitter). Function effects include associations between this genetic variation and behaviors, including symptoms of disorders associated with attention.
Figure 1Monochromatic representation of infant visual display. The actual presentation had red and green bars.
Dependent variables after controlling for age by time point and sex.
| AGE (months) | Residual PC | Residual RT | |||||
|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | ||
| Time 1 (Infancy) | Male | 3.61 | 0.83 | 0.11 | 0.97 | 0.06 | 1.21 |
| Female | 3.64 | 0.73 | 0.08 | 1.12 | −0.05 | 1.07 | |
| Combined | 3.62 | 0.79 | 0.10 | 1.05 | 0.00 | 1.14 | |
| Time 2 (Childhood) | Male | 154.11 | 21.69 | −0.06 | 1.01 | −0.10 | 0.63 |
| Female | 155.06 | 20.23 | 0.11 | 1.00 | −0.06 | 0.63 | |
| Combined | 154.57 | 20.95 | 0.02 | 1.00 | −0.08 | 0.63 | |
Abbreviations: PC, percent correct; RT, reaction time.
Parameter estimates from models predicting residual RT with .
| Empty | Full | Simplified | Add Sleep | Add SES | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Parameter | Mean | SE | Mean | SE | Mean | SE | Mean | SE | Mean | SE | |
| Fixed Effects | |||||||||||
| Intercept | −0.06 | 0.04 | −6.36** | 0.60 | −6.36** | 0.60 | −6.23** | 0.59 | −10.16** | 0.75 | |
| Level 1 (time point) | |||||||||||
| Infant | 4.78** | 1.53 | 4.76** | 1.53 | 4.56** | 1.53 | 5.72** | 0.98 | |||
| Child | 0a | 0.00 | 0a | 0.00 | 0b | 0.00 | 0b | 0.00 | |||
| Level 2 (individual) | |||||||||||
| rs1137070 (0 risk) | 0.27 | 0.57 | 0.27 | 0.56 | 0.35 | 0.56 | 3.91** | 0.50 | |||
| (1 risk) | 0.05 | 0.31 | 0.05 | 0.31 | 0.08 | 0.31 | 1.87** | 0.30 | |||
| (2 risk) | 0a | 0.00 | 0a | 0.00 | 0b | 0.00 | 0b | 0.00 | |||
| rs12843268 (0 risk) | 2.21** | 0.34 | 2.21** | 0.34 | 2.17** | 0.33 | 4.01** | 0.44 | |||
| (1 risk) | 2.06** | 0.21 | 2.06** | 0.20 | 2.00** | 0.20 | 2.04** | 0.20 | |||
| (2 risk) | 0a | 0.00 | 0a | 0.00 | 0b | 0.00 | 0b | 0.00 | |||
| rs909525 (0 risk) | 0.13 | 0.18 | 0.13 | 0.16 | 0.10 | 0.18 | 0.16 | 0.18 | |||
| (1 risk) | 0.13 | 0.14 | 0.13 | 0.14 | 0.11 | 0.14 | 0.16 | 0.14 | |||
| (2 risk) | 0a | 0.00 | 0a | 0.00 | 0b | 0.00 | 0b | 0.00 | |||
| lag time | 0.00** | 0.00 | 0.00** | 0.00 | 0.00** | 0.00 | 0.00** | 0.00 | |||
| sex | 0.22 | 0.32 | 0.22 | 0.27 | 0.25 | 0.27 | 2.05** | 0.25 | |||
| sleepiness | 0.02** | 0.01 | |||||||||
| SES | 0.00* | 0.00 | |||||||||
| time 1 * rs1137070 (0 risk) | 2.01 | 1.47 | 1.57 | 1.42 | 2.00 | 1.46 | 1.12 | 0.91 | |||
| (1 risk) | 0.58 | 0.70 | 0.54 | 0.70 | 0.60 | 0.70 | 0.50 | 0.69 | |||
| (2 risk) | 4.20 | 1.56 | 0a | 0.00 | 0a | 0.00 | 0b | 0.00 | |||
| time 2 * rs1137070 (0 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | 0b | 0.00 | |||
| (1 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | 0b | 0.00 | |||
| (2 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | 0b | 0.00 | |||
| time 1 * rs12843268 (0 risk) | −1.07 | 1.48 | −1.06 | 1.48 | −1.02 | 1.47 | −1.89* | 0.89 | |||
| (1 risk) | −1.88* | 0.86 | −1.84* | 0.86 | −1.80** | 0.86 | −1.89* | 0.85 | |||
| (2 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | |||
| time 2 * rs12843268 (0 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | |||
| (1 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | |||
| (2 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | |||
| time 1 * rs909525 (0 risk) | −0.94 | 0.79 | −0.49 | 0.70 | −0.95 | 0.79 | −0.99 | 0.78 | |||
| (1 risk) | −0.32 | 0.62 | −0.30 | 0.62 | −0.33 | 0.62 | −0.34 | 0.61 | |||
| (2 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | |||
| time 2 * rs909525 (0 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | |||
| (1 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | |||
| (2 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | |||
| time 1 * rs1137070 (0 risk) * sex | −1.00 | 1.08 | −0.26 | 0.87 | −1.02 | 1.07 | −2.84** | 1.05 | |||
| (1 risk) | 0.80 | 1.20 | 0.82 | 1.20 | 0.77 | 1.20 | 0a | 0.00 | |||
| (2 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | |||
| time 2 * rs1137070 (0 risk) * sex | 1.83** | 0.38 | 1.83** | 0.34 | 1.72** | 0.38 | 0a | 0.00 | |||
| (1 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | |||
| (2 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | |||
| time 1 * rs12843268 (0 risk) * sex | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | |||
| (1 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | |||
| (2 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | |||
| time 2 * rs12843268 (0 risk) * sex | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | |||
| (1 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | |||
| (2 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | |||
| time 1 * rs909525 (0 risk) * sex | 0.77 | 0.65 | −0.95 | 0.79 | 0.79 | 0.65 | 0.80 | 0.64 | |||
| (1 risk) | 0a | 0.00 | −0.33 | 0.62 | 0a | 0.00 | 0a | 0.00 | |||
| (2 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | |||||
| time 2 * rs909525 (0 risk) * sex | 0.00 | 0.15 | 0.03 | 0.15 | −0.01 | 0.15 | |||||
| (1 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | |||||
| (2 risk) | 0a | 0.00 | 0a | 0.00 | 0a | 0.00 | |||||
| Repeated | Time point 1 | 1.30 | 0.13 | 1.33 | 0.14 | 1.34 | 0.14 | 1.32 | 0.14 | 1.28 | 0.13 |
| Measures | Time point 2 | 0.40 | 0.04 | 0.72 | 0.01 | 0.07 | 0.01 | 0.07 | 0.01 | 0.07 | 0.01 |
| Num. of Parameters | 3.00 | 23 | 21 | 24 | 22 | ||||||
| Schwarz’s BIC | 1015.65 | 705.38 | 705.83 | 706.76 | 712.76 | ||||||
**Significant at p < 0.01. *Significant at p < 0.05. Significant values indicate that the estimate is different from zero. We report results under tests of fixed effects for gene by trial interactions to determine if trajectories differ by genotype. .
Figure 2Mean residual reaction time (RT; controlling for age) represents the subject’s position in the distribution of infant or child scores at each time point. Because Monoamine oxidase A (MAOA) is on the X chromosome, it is only possible for boys to have one of two genotypes. Boys with either genotype decrease (improve) in their relative RT between infancy and childhood. Girls with the CT genotype decrease in their relative RT but girls with the CC genotype increase in their relative RT.
Means and standard deviations of RT and residual RT scores by time point and sex.
| Raw RT | Residual RT | ||||||
|---|---|---|---|---|---|---|---|
| Count | Mean | SD | Mean | SD | |||
| Infancy | Male | T | 67 | 1840.75 | 418.98 | 0.12 | 1.33 |
| C | 35 | 1784.86 | 293.76 | −0.06 | 0.93 | ||
| Female | TT | 48 | 1763.96 | 303.61 | −0.12 | 0.97 | |
| CT | 38 | 1834.21 | 391.54 | 0.09 | 1.25 | ||
| CC | 11 | 1728.18 | 259.92 | −0.24 | 0.82 | ||
| Childhood | Male | T | 67 | 364.10 | 45.20 | −0.01 | 0.66 |
| C | 35 | 352.60 | 27.89 | −0.29 | 0.54 | ||
| Female | TT | 48 | 364.52 | 39.55 | −0.09 | 0.60 | |
| CT | 38 | 365.49 | 37.97 | −0.06 | 0.66 | ||
| CC | 11 | 351.30 | 29.73 | 0.06 | 0.72 | ||
Note. Age was controlled by residualizing RT within time point and saving the standardized scores. Residual RT can be interpreted as a Z-score.